the solution was washed successively with ice-cold 1 mol dmϪ3
aq. Na2S2O3 and cold 0.5 mol dmϪ3 aq. TEA hydrogen carb-
onate, dried by filtration through cotton wool, and concen-
trated. A solution of the residue in toluene–ethyl acetate (7:3)
was passed through a silica gel pad using, first, the same solvent
and then dichloromethane–methanol (9:1) for the elution.
The DCM–MeOH fraction was washed with 0.5 mol dmϪ3 aq.
TEA hydrogen carbonate and concentrated to produce the
phosphodiester 3a (265 mg, 97%) as a chromatographically
homogeneous amorphous solid, δP Ϫ0.54 (quintet, JP, H 4.7).
The phosphodiester 3a (50 mg, 0.058 mmol) was dissolved
in CH2Cl2 (2.0 cm3), piperidine (0.4 cm3) was added, and the
mixture was kept at rt for 30 min and then concentrated at 0.01
mmHg (oil-pump). A solution of the residue in methanol–
petroleum spirit (1:2; 50 cm3) was extracted with water (20 cm3)
and the aqueous layer was concentrated to give the phospho-
monoester 4a (41 mg, 95%; 92% based on compound 1a) as a
chromatographically pure amorphous solid, [α]D24 ϩ36 (c 1,
CHCl3); Rf 0.38 (solvent A); δH 1.55 (4 H, br, 2 × CH2-
CH2CH2N), 1.75 (8 H, br, 4 × CH2CH2N), 3.00 (8 H, br,
4 × CH2N), 3.46 (3 H, s, OMe), 3.95 (1 H, dt, J5,6a = J6a,P = 5.6,
6-Ha), 4.03 (1 H, ddd, J6b,P 5.6, J6a,6b 11.3, 6-Hb), 4.26 (1 H, ddd,
J5,6b 2.1, 5-H), 5.16 (1 H, d, J1,2 3.5, 1-H), 5.21 (1 H, dd, J2,3 10.1,
2-H), 5.52 (1 H, t, J3,4 = J4,5 = 9.7, 4-H), 6.12 (1 H, dd, 3-H) and
7.20–8.00 (15 H, m, 3 × Ph); δP 3.18 (t, J 5.6); ES-MS(Ϫ) m/z
584.89 (100%, [M Ϫ H]Ϫ) (free acid C28H27O12P requires M,
586.12).
dd, 2-H), 3.90 and 4.12 (AB, Jgem 12.2, 6-Ha and 6-Hb), 4.31
(1 H, dt, J2,3 = J3,P = 9.6, 3-H), 4.44 (1 H, d, J1,2 7.6, 1-H), 4.52
(1 H, d, J3,4 3.1, 4-H), 4.76 and 4.86 (AB, Jgem 11.2, PhCH2),
5.54 (1 H, s, PhCH) and 7.10–7.60 (10 H, m, 2 × Ph); δP 2.14
(d, J 9.6); ES-MS(Ϫ) m/z 451.03 (100%, [M Ϫ H]Ϫ) (free acid
C21H25O9P requires M, 452.12).
Methyl 3-O-benzoyl-4,6-O-benzylidene-ꢁ-D-galactopyranoside
2-phosphate, dipiperidinium salt 4d
This compound was prepared from compound 1d (100 mg) via
the consecutive formation of the H-phosphonate 2d [134 mg,
96%; δP 3.29 (dd, 1JP, H 641.8, 3JP, H 10.8); δH 6.95 (d, HP)] and the
phosphodiester 3d [177 mg, 97%; δP Ϫ1.41 (dt, JP,CH 5.9, JP,2-H
2
10.3)] followed by P-deprotection of the derivative 3d (40 mg)
as described for the preparation of the phosphate 4a. This
produced the phosphomonoester 4d (34 mg, 100%; 93% based
on compound 1d) as a chromatographically pure amorphous
solid, [α]D24 ϩ52 (c 1, CHCl3); Rf 0.43 (solvent A); δH 1.52 (4 H, br,
2 × CH2CH2CH2N), 1.78 (8 H, br, 4 × CH2CH2N), 3.00 (8 H,
br, 4 × CH2N), 3.55 (3 H, s, OMe), 3.62 (1 H, s, 5-H), 4.07 and
4.34 (AB, Jgem 12.5, 6-Ha and 6-Hb), 4.49 (1 H, J1,2 7.8, 1-H),
4.52 (1 H, d, 4-H), 4.55 (1 H, dt, J2,3 = J2,P = 9.8, 2-H), 5.15 (1 H,
dd, J3,4 3.5, 3-H), 5.47 (1 H, s, PhCH) and 7.10–8.20 (10 H,
m, 2 × Ph); δP 1.39 (d, J 9.8); ES-MS(Ϫ) m/z 464.99 (100%,
[M Ϫ H]Ϫ) (free acid C21H23O10P requires M, 466.10).
2,3,4,6-Tetra-O-benzyl-ꢀ,ꢁ-D-glucopyranosyl phosphate, mono-
piperidinium salt 4e
1,2,3,6-Tetra-O-benzoyl-ꢀ-D-mannopyranose 4-phosphate,
This compound was prepared from compound 1e (100 mg;
anomeric mixture, α:β ≈ 3.4:1) via the consecutive formation
of the H-phosphonate 2e [254 mg, 99%; δP 1.87 (dd, 1JP, H 649.0,
3JP, H 8.3, Pα) and 2.29 (dd, 1JP, H 650.4, 3JP, H 9.1, Pβ); δH 7.08 (d,
HPα) and 7.14 (d, HPβ); α:β ≈ 3.4:1] and the phosphodiester
bis(triethylammonium) salt 4b
The tetrabenzoate 1b (100 mg) was first converted to the H-
phosphonate 2b [117 mg, 93%; δP 4.71 (dd, JP, H 632.6, JP, H
11.3); δH 6.99 (d, HP)] and then to the phosphodiester 3b
[139 mg, 95%; δP Ϫ1.11 (dt, JP,CH 5.4, JP,4-H 9.7)] as described
in the preparation of the phosphate 4a.
1
3
3e [303 mg, 93%; δP Ϫ1.85 (dt, JP,CH 5.6, JP,1-H 8.2, Pβ) and
2
2
Ϫ1.34 (dt, JP,CH 4.9, JP,1-H 8.0, Pα); α:β ≈ 3.4:1] followed by
2
The phosphodiester 3b (29 mg, 0.031 mmol) was dissolved
in CH2Cl2 (0.5 cm3), piperidine (0.1 cm3) was added and the
mixture was kept at rt for 30 min, then diluted with CH2Cl2,
washed with 0.5 mol dmϪ3 HCl, dried by filtration through
cotton wool, and concentrated. A solution of the residue in
toluene–ethyl acetate (7:3) was passed through a silica gel pad
using, first, the same solvent and then dichloromethane–
methanol (9:1) for the elution. The DCM–MeOH fraction was
washed with 0.5 mol dmϪ3 aq. TEA hydrogen carbonate and
concentrated to produce the phosphomonoester 4b (25 mg,
94%; 83% based on compound 1b) as a chromatographically
pure amorphous solid, [α]D24 ϩ11 (c 1, CHCl3); Rf 0.08 (solvent
B); δH 0.98 (18 H, t, J 7.2, 6 × CH3CH2N), 2.59 (12 H, q,
6 × CH3CH2N), 4.45 (1 H, ddd, J5,6a 6.4, J4,5 9.8, 5-H), 4.64
(1 H, dd, J6a,6b 11.9, 6-Ha), 4.85 (1 H, dd, J5,6b 1.5, 6-Hb), 5.51
(1 H, q, J3,4 = J4,5 = J4,P = 9.8, 4-H), 5.78 (1 H, dd, J1,2 1.9, J2,3
3.4, 2-H), 5.83 (1 H, dd, 3-H), 6.45 (1 H, d, 1-H) and 7.00–8.20
(20 H, m, 4 × Ph); δP 1.26 (d, J 9.8); ES-MS(Ϫ) m/z 675.16
(100%, [M Ϫ H]Ϫ) (free acid C34H29O13P requires M, 676.13).
the P-deprotection of the derivative 3e (64 mg) as described for
the preparation of the phosphate 4a. This produced the
phosphomonoester 4e (48 mg, 94%; 87% based on compound
1e) as an amorphous solid, Rf 0.50 (solvent A); δH (inter alia)
1.40 (2 H, br, CH2CH2CH2N), 1.65 (4 H, br, 2 × CH2CH2N),
3.03 (4 H, br, 2 × CH2N), 5.20 (dd, J1,2 9.8, J1,P 8.0, 1-Hβ) and
5.83 (dd, J1,2 2.4, J1,P 6.0, 1-Hα); δP 0.28 (d, J 8.0, Pβ) and 0.44 (d,
J 6.0, Pα); α:β ≈ 3.4:1; ES-MS(Ϫ) m/z 619.1 (100%, [M Ϫ H]Ϫ)
(free acid C34H37O9P requires M, 620.22).
Methyl 2,3,6-tri-O-benzoyl-ꢁ-D-galactopyranoside 4-phosphate,
dipiperidinium salt 4f
This compound was prepared from compound 1f (160 mg) via
the consecutive formation of the H-phosphonate 2f [208 mg,
1
3
100%; δP 3.84 (dd, JP, H 631.7, JP, H 11.6); δH 6.98 (d, HP)] and
the phosphodiester 3f [260 mg, 96%; δP Ϫ0.59 (dt, JP,CH 5.5,
2
JP,4-H 9.9)] followed by P-deprotection of the derivative 3f (60
mg) as described for the preparation of the phosphate 4a. This
produced the phosphomonoester 4f (51 mg, 97%; 93% based on
compound 1f) as a chromatographically pure amorphous solid,
[α]D24 ϩ28 (c 1, CHCl3); Rf 0.38 (solvent A); δH 1.60 (4 H, br,
2 × CH2CH2CH2N), 1.80 (8 H, br, 4 × CH2CH2N), 3.06 (8 H,
br, 4 × CH2N), 3.44 (3 H, s, OMe), 4.16 (1 H, dd, J5,6a 2.6, J5,6b
8.8, 5-H), 4.47 (1 H, dd, J6a,6b 12.1, 6-Ha), 4.62 (1 H, d, J1,2 7.8,
1-H), 4.66 (1 H, dd, 6-Hb), 4.86 (1 H, dd, J3,4 3.2, J4,P 11.0, 4-H),
5.31 (1 H, dd, J2,3 10.4, 3-H), 5.63 (1 H, dd, 2-H) and 7.20–8.00
(15 H, m, 3 × Ph); δP 2.01 (d, J 11.0); ES-MS(Ϫ) m/z 585.07
(100%, [M Ϫ H]Ϫ) (free acid C28H27O12P requires M, 586.12).
Methyl 2-O-benzyl-4,6-O-benzylidene-ꢁ-D-galactopyranoside
3-phosphate, dipiperidinium salt 4c
This compound was prepared from compound 1c (55 mg) via
the consecutive formation of the H-phosphonate 2c [73 mg,
94%; δP 5.79 (dd, 1JP, H 630.7, 3JP, H 10.7); δH 7.05 (d, HP)] and the
phosphodiester 3c [94 mg, 94%; δP Ϫ0.79 (dt, JP,CH 4.4, JP,3-H
2
8.0)] followed by P-deprotection of the derivative 3c (20 mg)
as described for the preparation of the phosphate 4a. This
produced the phosphomonoester 4c (17 mg, 100%; 88% based
on compound 1c) as a chromatographically pure amorphous
solid, [α]D24 ϩ24 (c 1, CHCl3); Rf 0.40 (solvent A); δH 1.52 (4 H, br,
2 × CH2CH2CH2N), 1.78 (8 H, br, 4 × CH2CH2N), 3.00 (8 H,
br, 4 × CH2N), 3.24 (1 H, s, 5-H), 3.60 (3 H, s, OMe), 3.62 (1 H,
Benzyl 2-acetamido-3,6-di-O-benzoyl-2-deoxy-ꢀ-D-glucopyr-
anoside 4-phosphate, dipiperidinium salt 4g
This compound was prepared from compound 1g (60 mg) via
the consecutive formation of the H-phosphonate 2g [78 mg,
J. Chem. Soc., Perkin Trans. 1, 2000, 1195–1198
1197